Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00152243Phase 3Completed
A Phase 3 trial of tegafur + uracil in gastric cancer (GC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Jun 1997; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00152243.